Main Menu

Introduction of Rotavirus vaccines into Latin american National Programs: Experience and Impact

Rating

Share

Digg! Reddit! Del.icio.us! Google! Live! Facebook! Slashdot! Netscape! Technorati! StumbleUpon! Spurl! Wists! Simpy! Newsvine! Blinklist! Furl! Fark! Blogmarks! Yahoo! Smarking! Netvouz! Shadows! RawSugar! Ma.gnolia! PlugIM! Squidoo! BlogMemes! FeedMeLinks! BlinkBits! Tailrank! linkaGoGo!

Info

Description

 

 

22 Feb 2010

 

Bio - Dr Bill Hausdorff : Bill Hausdorff joined GSK Biologicals in 2003, and is currently Head, Value and Scientific Strategy for Paediatric Vaccines, based in Wavre, Belgium. Prior to that position he served as Director of Epidemiology and Scientific Strategy at GSK.

His academic background includes a PhD in Biology from Johns Hopkins University/the U.S. National Institutes of Health, and a post-doctoral fellowship in molecular pharmacology at Duke University in the US. Subsequently he served as a Technical Advisor with the US Centers for Disease Control and Prevention, based at the US Agency for International Development in Wash DC and Cairo, Egypt. There he worked to expedite introduction of new vaccines into developing country immunization programs. In 1995 he joined Wyeth Vaccines in the Scientific Affairs and Research Strategy group.

His major focus at GSK Biologicals is on the development and introduction of vaccines to prevent diseases caused by the pneumococcus, meningococcus, rotavirus, and pathogens respresented in DTP-combination vaccines. He is the author of numerous scientific articles and book chapters, including extensive publications on the epidemiology of S. pneumoniae disease.

Bio - Dr Jose Santos : Prior to his latest Academic Appointment in the Department of Experimental Medicine, School of Medicine at the National Autonomous University of Mexico, from 2004-2009, Dr. José Ignacio Santos

was the General Director of Hospital Infantil de México Federico Gómez, the oldest and one of the foremost pediatric academic institutions in the Region of the Americas and one of Mexico's National Institutes of Health. From 1997-2004 Dr. Santos was Director of Mexico's National Infant and Adolescent Health Program and Immunization Program as well as Mexico's liaison member of the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention.

Dr. Santos also serves other international health agencies including the board of trustees of the International Center for Diarrheal Research (ICDDRB) in Dhaka, Bangladesh, the Measles Working Group of SAGE, the Strategic Advisory Group of Experts (the principal advisory group to the World Health Organization (WHO) for vaccines and immunization), board of counselors of Pediatric Dengue Vaccine Initiative (PDVI), as well as on the Data and safety Monitoring Board for the WHO´s Measles Aerosol Project.

Dr. Santos received his medical and pediatric training at Stanford University and Clinical Immunology and Infectious Diseases training at the University of Utah. He is past president of the Mexican and Pan-American Infectious Diseases Societies and is a fellow of the Infectious Disease Society of America (IDSA). He is a member of the advisory group of PGRP (Pediatric Global Research Priorities) of the American Academy of Pediatrics.
He has trained over 60 Fellows in Pediatric Infectious Diseases from 13 Latin American countries, including Mexico. His research and public health interests have focused on pediatric infectious diseases and on the critical evaluation and introduction of new vaccines. He is the author or co-author of 275 peer-reviewed publications.


Dr Bill Hausdorff

Head, Value and Scientific Strategy for Paediatric Vaccines, Global Vaccine Development. GSK Biologicals, Belgium

&

Dr Jose Santos MD, MSC

Professor and Head of the Infectious Diseases Unit

Department of Experimental Medicine

School of Medicine, National Autonomous University of Mexico